# Nintedanib

NDC: 42799-972
Generic name: nintedanib
Labeler / Manufacturer: Edenbridge Pharmaceuticals LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260403

FDA application: ANDA219819

## Active ingredients

- NINTEDANIB ESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42799-972"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42799-972
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43dae004-eaf6-4411-8c3d-db7ab2c3b41e